Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Dec;52(12):1698-702.
doi: 10.1136/gut.52.12.1698.

Coeliac disease: in vivo toxicity of the putative immunodominant epitope

J S Fraser  1 , W Engel, H J Ellis, S J Moodie, E L Pollock, H Wieser, P J Ciclitira
Affiliations

Coeliac disease: in vivo toxicity of the putative immunodominant epitope

J S Fraser et al. Gut. 2003 Dec.

Abstract

Background: Peptides from alpha-gliadins have been used to characterise the immunodominant coeliac toxic epitope. A peptide corresponding to amino acid residues 57-73 of A-gliadin causes peripheral blood mononuclear cells from coeliac patients to secrete interferon gamma (IFN-gamma); gluten specific small intestinal T cell clones proliferate in response to peptides corresponding to residues 57-68 and 62-75 of alpha-gliadins. We wished to investigate whether a peptide corresponding to residues 56-75 of alpha-gliadins exacerbates coeliac disease in vivo.

Methods: Four adults with coeliac disease, all of whom were on a gluten free diet, underwent three challenges. Peptic-tryptic gliadin (PTG 1 g) served as a positive control. The test peptide and a negative control peptide were studied on separate occasions. The peptides were instilled into the duodenum and biopsies were taken before the infusion, and two, four, and six hours after commencing the infusions, using a Quinton hydraulic multiple biopsy capsule. Biopsy specimens were assessed blindly for villus height to crypt depth ratio (VH:CD), enterocyte cell height (ECH), and intraepithelial lymphocyte (IEL) count. We used the Mann-Whitney U test, with 95% confidence intervals, for statistical analysis.

Results: VH:CD and ECH fell, and IEL increased significantly 4-6 hours after commencing infusions with both PTG and the test peptide in all subjects. The negative control peptide caused no significant changes to villus morphology, enterocyte height, or IEL count in any patient.

Conclusion: We have confirmed that the putative immunodominant epitope, a peptide corresponding to residues 56-75 of alpha-gliadins, exacerbates coeliac disease in vivo.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient No I. Before challenge with peptic-tryptic digest of gliadin.
Figure 2
Figure 2
Patient No I. After four hours, enterocyte height was reduced and villous blunting occurred.
Figure 3
Figure 3
Mean CD3 counts at four time points following challenge with peptic-tryptic digest of gliadin (PTG), peptide 8 (G8), and a negative control (C1 peptide). IEL, intraepithelial lymphocytes.
See this image and copyright information in PMC

References

    1. Biagi F, Ellis HJ, Parnell ND, et al. A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation? Aliment Pharmacol Ther 1999;13:945–50. - PubMed
    1. Gjertsen HA, Lundin KE, Sollid LM, et al. T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol 1994;39:243–52. - PubMed
    1. Kontakou M, Przemioslo RT, Sturgess RP, et al. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge. Gut 1995;37:52–7. - PMC - PubMed
    1. Lahteenoja H, Maki M, Viander M, et al. Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease. Am J Gastroenterol 2000;95:2880–7. - PubMed
    1. Lundin KE, Sollid LM, Anthonsen D, et al. Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology 1997;112:752–9. - PubMed

Publication types